```html

Xanthomatous Plaques

What is Xanthomatous Plaques?

Xanthomatous plaques are raised, yellow‑to‑orange skin lesions that are composed of lipid‑laden macrophages (foam cells) in the dermis. They often appear as smooth or slightly rough patches that may be flat or dome‑shaped, ranging from a few millimeters to several centimeters in diameter. While they are most commonly found on the elbows, knees, buttocks, and extensor surfaces, they can develop anywhere on the body, including the eyelids (xanthelasma) and the tendons (tendon xanthomas). In most cases, the plaques are benign, but because they frequently signal an underlying metabolic or systemic disorder, proper evaluation is essential.

The term “xanthoma” comes from the Greek word xanthos meaning “yellow.” When the lesions coalesce into larger, plaque‑like formations, they are described as “xanthomatous plaques.” They are not contagious, do not usually cause pain, and are generally asymptomatic unless they become inflamed, infected, or located in a cosmetically sensitive area.

Common Causes

Several metabolic, genetic, and systemic conditions can lead to the development of xanthomatous plaques.

• Familial hypercholesterolemia (FH): Autosomal‑dominant disorder with markedly elevated LDL‑cholesterol.
• Familial combined hyperlipidemia: Elevated LDL and/or triglycerides without a single gene defect.
• Primary biliary cholangitis (PBC): Chronic cholestatic liver disease that can cause eruptive xanthomas.
• Type IIa hyperlipoproteinemia (LDL‑cholesterol excess): Often presents with tendon xanthomas.
• Type III hyperlipoproteinemia (Dysbetalipoproteinemia): Characterized by palmar xanthomas and tuberous plaques.
• Diabetes mellitus with poor glycemic control: Can provoke eruptive xanthomas on buttocks and thighs.
• Acquired lipid disorders secondary to medications: Example – protease inhibitors, isotretinoin, or corticosteroids.
• Chronic renal disease / nephrotic syndrome: Protein loss leads to hyperlipidemia and xanthomas.
• Systemic inflammatory conditions: Sarcoidosis or granulomatous disease may mimic xanthomatous plaques.
• Rare genetic disorders: Cerebrotendinous xanthomatosis, Niemann‑Pick disease type C.

Associated Symptoms

Depending on the underlying cause, patients may notice additional signs:

• Yellowish deposits on the eyelids (xanthelasma).
• Tendon thickening, especially over the Achilles or extensor tendons.
• Itching or mild burning sensation if plaques become inflamed.
• Cardiovascular symptoms – chest pain, shortness of breath, or claudication, suggesting atherosclerosis.
• Abdominal pain or hepatomegaly in liver‑related disorders.
• Fatigue, weight loss, or night sweats in systemic inflammatory conditions.
• Family history of early‑onset heart disease or lipid abnormalities.

When to See a Doctor

Because xanthomatous plaques can be an early warning sign of serious disease, prompt medical attention is warranted if you experience any of the following:

• Rapid appearance of multiple plaques over weeks.
• Plaques that become painful, red, or ooze pus.
• Sudden changes in size or color.
• Family history of premature heart disease or known lipid disorder.
• Accompanying symptoms such as chest pain, shortness of breath, or leg swelling.
• Any new skin lesion in a child or teenager (may indicate a genetic lipid disorder).

Diagnosis

Evaluation typically proceeds in three steps: clinical assessment, laboratory testing, and, when needed, skin biopsy or imaging.

1. Clinical Examination

• Distribution, size, and texture of plaques are documented.
• Assessment for tendon involvement or xanthelasma.
• Full skin exam to rule out mimickers (e.g., granuloma annulare, necrobiosis lipoidica).

2. Laboratory Studies

• Lipid panel: total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Liver function tests (ALT, AST, alkaline phosphatase, GGT) – especially if cholestasis suspected.
• Renal function (creatinine, eGFR) and urine protein to screen for nephrotic syndrome.
• Blood glucose/HbA1c for diabetes.
• Genetic testing for FH (LDLR, APOB, PCSK9) when family history is strong.
• Inflammatory markers (CRP, ESR) if systemic disease is considered.

3. Skin Biopsy (if needed)

A 4‑mm punch biopsy of a plaque stained with H&E will show foamy macrophages within the dermis. Special stains (Oil‑Red‑O) confirm lipid content. Biopsy is usually reserved for atypical lesions or when the diagnosis is uncertain.

4. Imaging

• Ultrasound of tendons to detect tendon xanthomas.
• Coronary artery calcium scoring or carotid Doppler if severe dyslipidemia is found.

Treatment Options

Therapy targets two goals: (1) removal or reduction of the plaques and (2) treatment of the underlying disorder.

Medical Management

• Statins (e.g., atorvastatin, rosuvastatin): First‑line for LDL‑cholesterol reduction; can cause plaque regression in 6‑12 months.
• Ezetimibe: Added when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab): Highly effective for FH or refractory hyperlipidemia.
• Fibrates (gemfibrozil, fenofibrate): Preferred when triglycerides are markedly elevated.
• Bile‑acid sequestrants (cholestyramine): Useful in cholestatic liver disease.
• Niacin: May improve HDL‑C but limited by flushing; used rarely.
• Glucose‑lowering agents (metformin, SGLT2 inhibitors): Essential if diabetes is present.
• Immunomodulators (e.g., corticosteroids, methotrexate): Reserved for inflammatory mimickers.

Procedural / Dermatologic Treatments

• Laser therapy (Q‑switched Nd:YAG, CO₂ laser): Can flatten plaques, especially on the face.
• Cryotherapy: May be used for isolated small lesions.
• Intralesional corticosteroid injection: Reduces inflammation if plaques become erythematous.
• Surgical excision: Considered for large, cosmetically distressing plaques after lipid control.

Home and Lifestyle Measures

• Adopt a heart‑healthy diet: Mayo Clinic low‑cholesterol guidelines.
• Increase soluble fiber (oats, beans, apples) to lower LDL.
• Engage in at least 150 minutes of moderate aerobic exercise per week.
• Maintain a healthy weight; weight loss can improve lipid profile.
• Quit smoking – it accelerates atherosclerosis and can worsen plaques.
• Limit alcohol intake, especially if triglycerides are high.
• Regularly monitor lipid levels as directed by your clinician.

Prevention Tips

While you cannot prevent genetic lipid disorders, you can lower the risk of developing xanthomatous plaques by controlling modifiable factors.

• Screen early: Adults should have a lipid panel at least once every 4‑6 years; earlier testing is advised if there is a family history.
• Stay active: Physical activity raises HDL‑C and improves overall cardiovascular health.
• Eat wisely: Emphasize fruits, vegetables, whole grains, lean proteins, and healthy fats (e.g., omega‑3 rich fish).
• Medication adherence: Take statins or other lipid‑lowering agents exactly as prescribed.
• Regular follow‑up: Keep scheduled appointments for blood work and medication adjustments.
• Avoid high‑sugar, high‑fat processed foods: These can increase triglycerides and LDL.
• Manage comorbidities: Control diabetes, hypertension, and thyroid disorders promptly.

Emergency Warning Signs

---

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institute of Health (NIH) – National Heart, Lung, and Blood Institute, American Heart Association, Cleveland Clinic, and peer‑reviewed articles in Journal of the American Academy of Dermatology and Circulation. Information is intended for educational purposes and does not replace professional medical advice.

```